STRS Ohio’s Gossamer Bio GOSS Stock Holding History

STRS Ohio’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,000	Closed	-$50K	–	2095
2019 Q3	$50K	Hold	3,000	–	–	﹤0.01%	1882
2019 Q2	$66K	Hold	3,000	–	–	﹤0.01%	1886
2019 Q1	$65K	Buy	+3,000	New	+$62.6K	﹤0.01%	1847

Other funds holding GOSS

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

STRS Ohio's GOSS Position: Q4 2019 in Review

STRS Ohio sold out of Gossamer Bio (GOSS) in Q4 2019, closing a stake of 3,000 shares — an estimated $50K sold.

STRS Ohio first reported a position in GOSS in Q1 2019 and held it in 3 quarters. The position peaked at $66K in Q2 2019. 88 funds tracked by Wall St. Rank hold GOSS as of Q4 2019.

STRS Ohio reported no remaining Gossamer Bio position as of Q4 2019 after selling out during the quarter.
STRS Ohio sold 3,000 Gossamer Bio shares in Q4 2019, an estimated $50K.
STRS Ohio first reported a position in Gossamer Bio in Q1 2019 and held it in 3 quarters.
STRS Ohio's Gossamer Bio position peaked at $66K in Q2 2019.
88 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2019.

Based on STRS Ohio's 13F filing for Q4 2019, filed 24 Jan 2020.